WWW.DISSERTATION.XLIBX.INFO
FREE ELECTRONIC LIBRARY - Dissertations, online materials
 
<< HOME
CONTACTS



«What is in this leaflet This leaflet answers some of the common questions about ORATANE capsules. It does not contain all the available information. ...»

Consumer Medicine Information

®

ORATANE

Isotretinoin 5 mg, 10 mg, 20 mg, 30 mg and 40 mg

Capsules

What is in this leaflet

This leaflet answers some of the common questions about ORATANE capsules. It

does not contain all the available information.

It does not take the place of talking to your doctor or pharmacist.

All medicines have risks and benefits. Your doctor has weighed the risks or you

taking ORATANE capsules against the benefit the medicine is expected to have for you.

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

Keep this leaflet with the medicine. You may need to read it again.

What ORATANE is used for The active ingredient in ORATANE capsules is isotretinoin, a substance very similar to vitamin A. ORATANE belongs to a group of medicines called retinoids.

ORATANE capsules are used to treat acne. Of the many acne medicines, ORATANE is used for more severe cases.

ORATANE capsules work by cutting down the amount of oily substances (sebum) made by our glands in your skin. ORATANE capsules will also help to reduce the bacteria, inflammation and open clogged pores.

Your doctor may have prescribed ORATANE for another purpose.

Ask your doctor if you have any questions about why ORATANE has been prescribed for you.

ORATANE capsules are not addictive.

Before you take ORATANE When you must not take ORATANE

Do not take ORATANE capsules if:

1. You are pregnant or for at least one month before you intend to become pregnant. If you fall pregnant while taking ORATANE capsules there is an extremely high risk of having a baby that is severely deformed. This means that you must use effective contraception for one month before, during and at least one month after treatment with ORATANE. It is recommended that two complementary forms of contraception including a barrier method should be used. Progesterone only contraceptive tablets (minipills) alone are an inadequate method of contraception while you are on isotretinoin.

2. You are breast-feeding. Breast-feeding must stop before ORATANE treatment can start. Do not breast-feed while taking ORATANE capsules.

3. You have had an allergic reaction to ORATANE capsules, Vitamin A, other retinoids or any ingredients listed at the end of this leaflet.

4. You are taking tetracycline antibiotics. These include Doxine® DoxyTM, Achromycin ® and Minomycin®,.

5. You have kidney or liver disease.

6. You have very high levels of fat (triglycerides, cholesterol) in your blood.

7. You have an excessive amount of Vitamin A in your diet (hypervitaminosis A).

8. The packaging is torn or shows signs of tampering, or if the capsules do not look quite right.

9. The expiry date (EXP) date printed on the pack has passed. If you take this medicine after the expiry has passed, it may not work as well.

If you are not sure if you should start taking ORATANE capsules, consult your doctor.

Do not give ORATANE capsules to children. There is very little information available on the effects of ORATANE in children.

Before you start to take ORATANE capsules

You must tell your doctor if:

1. You have allergies to other substances, such as foods, preservatives or dyes.

2. You have any other health problems or issues including:

 Diabetes, or family members with diabetes  Depression, or family members with depression  You drink large amounts of alcohol.

If you have not told your doctor about any of the above, tell him or her before starting ORATANE capsules.

Taking other medicines Tell your doctor if you are taking any other medicines including any that you have bought from a pharmacy, supermarket, or health food shop.

–  –  –

How to take ORATANE capsules How much to take Always take ORATANE exactly as your doctor or pharmacist tells you to.

The directions given may differ from information contained in this leaflet.

Your doctor will determine exactly how much ORATANE you need for your condition.

This will be matched especially to your needs and your bodyweight and may be adjusted by your doctor when it is known how you respond to ORATANE capsules.

How to take it ORATANE capsules should be swallowed whole with a glass of water or milk.

Do not open ORATANE capsules or take damaged ORATANE capsules.

Female patients should wait until the 2nd or 3rd day of their menstrual period before starting ORATANE capsules. This helps to ensure that you are not pregnant before you start to take ORATANE therapy.

When to take it ORATANE capsules are taken once or twice a day and must be taken with meals.

How long to take it Continue taking ORATANE capsules for as long as your doctor prescribes.

Your treatment with ORATANE will usually last 16 weeks. Sometimes a second course of treatment may be necessary. In the first few weeks your acne will probably get worse before it gets better. Do not worry as this is a sign the ORATANE capsules are working.

After this treatment period your skin should have cleared up significantly. Skin condition continues to improve even after ORATANE treatment has finished.





ORATANE capsules cannot improve scars or pitting that existed before commencement of treatment, but it will prevent further scarring.

If you forget to take ORATANE Capsules If you forget to take ORATANE, you should not make up for missing the dose by doubling the next dose.

You should simply continue with the next dose when it is due. If you have missed several doses please inform your doctor and follow the advice given to you.

If you take too much (Overdose) Immediately go to the Accident and Emergency at your nearest hospital or telephone the New Zealand National Poisons Information Centre (telephone 0800 764 766) if you think that you or anyone else may have taken too much ORATANE.

Do this even if there are no signs of discomfort or poisoning.

You may require urgent medical attention.

Signs of overdose include transient headache, vomiting, facial flushing, reddened lips, stomach pain, headache, dizziness and unsteady walking.

Keep telephone numbers for these places handy.

While you are taking ORATANE Things you must do If you become pregnant while taking ORATANE capsules, stop taking it and inform your doctor immediately.

ORATANE capsules can cause birth defects. This means that you must use strict birth control for at least 1 month before you start ORATANE, the whole time you are using ORATANE capsules and for at least 1 month after you finish taking ORATANE capsules.

There is no known risk to males who wish to father children.

Tell all doctors, dentists and pharmacists who are treating you, that you are on ORATANE capsules.

Tell your doctor if you feel ORATANE is not helping your condition.

But also tell your doctor if, for any reason, you have not taken your medicine exactly as prescribed.

If you are intending to do a lot of heavy lifting or exercise, tell your doctor.

ORATANE capsules can make your muscles and joints prone to stiffness or tenderness.

Be sure to keep all of your appointments with your doctor so he or she can monitor your progress.

You may require regular tests to check your liver, blood sugar levels and blood cholesterol levels.

Things you must not do Do not stop taking ORATANE capsules or change the dose without first checking with your doctor.

Do not let yourself run out of ORATANE capsules over the weekend or on holidays.

Do not use ORATANE capsules to treat other complaints unless told to by your doctor.

Do not give ORATANE capsules to anyone else, even if their symptoms seem similar to yours.

Do not donate blood while taking ORATANE capsules or for at least four weeks after stopping treatment.

Do not take any other medicines without first telling your doctor or pharmacist.

Things to be careful of Be careful driving or operating machinery until you know how ORATANE capsules affect you.

Normally ORATANE capsules would not affect your ability to drive a car or operate machinery. However altered night vision and other visual disturbances may occur while taking ORATANE capsules. Make sure you know how you react to ORATANE capsules before you drive a car, operate machinery or do anything else that might be dangerous if your vision is altered.

Wearing contact lenses during treatment with ORATANE capsules may cause discomfort. ORATANE capsules cause dry eyes so an artificial lubricant might be necessary. Otherwise you might need to compensate by wearing your glasses.

Avoid waxing or dermatological abrasions while taking ORATANE capsules and for six months after ORATANE treatment has stopped. Your skin may be more sensitive while on ORATANE capsules.

Avoid excessive sun exposure, and always apply sunscreen while taking ORATANE capsules. Your skin may be more prone to sunburn while on ORATANE capsules.

Avoid using facial peels, electrolysis and some hair treatments. Your skin and hair will be more delicate while taking ORATANE capsules.

Side effects Tell your doctor or pharmacist as soon as possible if you do not feel well while taking ORATANE capsules.

In addition to the beneficial effects of ORATANE it is possible that unwanted effects will occur during treatment, even when it is used as directed.

All medicines can have side effects. Sometimes they are serious, most of the time they are not. You may need medical treatment if you get some of the side effects.

Ask your doctor or pharmacist to answer any questions you may have.

–  –  –

However, Isotretinoin has been associated with inflammatory bowel disease (including regional ileitis) in patients without a prior history of intestinal disorders.

Patients experiencing severe (haemorrhagic [bloody]) diarrhoea should discontinue isotretinoin immediately.

–  –  –

These may be serious side effects and may require urgent medical attention. Serious side effects are rare.

This is not a complete list of all possible side effects. Others may occur in some people and there may be some unknown side effects.

You should tell your doctor about unwanted effects that occur during treatment. In some cases you doctor may want to reduce your dose or stop treatment.

Do not be alarmed by this list of possible side effects. You may not experience any of them.

If you are concerned about these or any other unexpected effects, please talk to your doctor.

After taking ORATANE capsules Storage Keep your capsules in the blister pack until it is time to take them. If you take the capsules out of the packaging they will not keep as well.

Keep ORATANE 5 mg capsules in a cool dry place where the temperature stays below 25C. Protect from light.

Keep ORATANE 10 mg capsules in a cool dry place where the temperature stays below 25C. Protect from light.

Keep ORATANE 20 mg capsules in a cool dry place where the temperature stays below 30C. Protect from light.

Keep ORATANE 30 mg capsules in a cool dry place where the temperature stays below 25C. Protect from light.

Keep ORATANE 40 mg capsules in a cool dry place where the temperature stays below 25C. Protect from light.

Do not store ORATANE capsules or any other medicine in the bathroom or near a sink.

Do not leave ORATANE capsules in the car or on windowsills. Heat and dampness can destroy some medicines.

Keep ORATANE capsules where children cannot reach them. A locked cupboard at least one-and-a-half metres above the ground is a good place to store medicines.

Disposal Tell your doctor if you stop taking the capsules or the capsules have passed their expiry date; ask your pharmacist what to do with any capsules that are left over.

Product Description What ORATANE capsules look like ORATANE 5 mg capsules are soft, oval, opaque white in colour containing a yellow/orange liquid.

ORATANE 10 mg capsules are soft, oval, opaque light violet in colour containing a yellow/orange liquid.

ORATANE 20 mg capsules are soft, oval, opaque maroon-red in colour containing a yellow/orange liquid.

Oratane 30 mg capsules are soft, oval opaque pink in colour, containing a yellow/orange liquid.

ORATANE 40 mg capsules are soft, oval, opaque light orange in colour containing a yellow/orange liquid.

Ingredients

Active ingredient:

Isotretinoin

Inactive ingredients:

Soya oil, DL-α-tocopherol, disodium edetate, butylated hydroxyanisole, partly hydrogenated soya oil, yellow beeswax, hydrogenated soya oil.

The capsule shells contain:

Gelatin, glycerol, sorbitol solution 70% (non-crystallising), titanium dioxide and water (purified).

10 mg capsules only: Iron oxide black (CI 77499) and Ponceau Red (CI 16255).

20 mg capsules only: Indigo carmine (CI 73015) and Ponceau Red (CI 16255).

30 mg capsules only: Iron oxide red 40 mg capsules only: Sunset yellow (CI 15985).

Further Information If you have any questions about ORATANE capsules, please ask your doctor or pharmacist. Further information may also be obtained from Douglas Pharmaceuticals Ltd.

Supplier Douglas Pharmaceuticals Limited PO Box 45-027 Auckland 0651 New Zealand Ph: (09) 835-0660 Fax: (09) 835-0665 Date of Preparation



Similar works:

«Interim Evaluation of the Sore Throat Management Component of the New Zealand Rheumatic Fever Prevention Programme Quantitative Findings Final Technical Report of Quantitative Findings October 2015 Whāia te iti kahurangi, ki te tuohu koe me maunga teitei Pursue that which is precious, and do not be deterred by anything less than a lofty mountain PREPARED FOR: Ministry of Health CLIENT REPORT No: FW15039 Quantitative Findings: Interim Evaluation of Sore Throat Component of the NZ RFPP October...»

«Mental Health Treatment Preferences for Persons of Mexican Heritage Item type text; Electronic Dissertation Authors Sorrell, Tanya Renee Publisher The University of Arizona. Rights Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author. Downloaded...»

«Brain Stents Artery Allies Department of Neurosurgery Introduction Brain stents are devices implanted in the brains of people with high risk conditions of the brain arteries. Brain stents save and improve lives every day, and University of Michigan specialists have developed great expertise in their use. Our team includes neurosurgeons and Neuro Interventional Radiologists (doctors with expertise in x ray guided brain procedures) as well as nurses and other health professionals. We prepared...»

«MERIDIAN HEALTH BOARD OF TRUSTEES Officers: Chairperson Vice Chairperson Treasurer Secretary President Immediate Past Chairperson Assistant Secretary Class of 2016 Class of 2015 Class of 2014 Alfred J. Schiavetti, Jr. Gordon N. Litwin, Esq. Richard Amdur, Esq. Peter S. Reinhart, Esq. Peter S. Goldman John Garbarino Vacancy Ivan Brown Gregg Azcuy Vacancy Vacancy Luke Kealy, Esq. Vacancy Thomas Dolan Vacancy Vacancy Honorary (Two year term – may serve unlimited successive terms) Martin Epstein...»

«DISSERTATIONES MEDICINAE UNIVERSITATIS TARTUENSIS OKSANA JAGUR Temporomandibular joint diagnostic imaging in relation to pain and bone characteristics. Long-term results of arthroscopic treatment.DISSERTATIONES MEDICINAE UNIVERSITATIS TARTUENSIS DISSERTATIONES MEDICINAE UNIVERSITATIS TARTUENSIS OKSANA JAGUR Temporomandibular joint diagnostic imaging in relation to pain and bone characteristics. Long-term results of arthroscopic treatment. Faculty of Medicine, University of Tartu, Tartu,...»

«An Introduction to Using CINAHL Through EBSCOhost What is CINAHL? CINAHL stands for the Cumulative Index of Nursing and Allied Health Literature and is the largest and most in-depth nursing research database. The CINAHL Complete database provides full text for 1,500 journals, and indexing for 5,500 journals from the fields of nursing and allied health. The database contains nearly 5 million records. Offering complete coverage of English-language nursing journals and publications from the...»

«STATE OF NEW YORK DEPARTMENT OF HEALTH 161 Delaware Avenue Delmar, NY 12054-1393 Antonia C. Novello, M.D., M.P.H., Dr. P.H. Dennis P. Whalen Commissioner Executive Deputy Commissioner October 20, 2005 DAL/DQS: 05-10 Subject: Nursing Home Requirements to Report to Department of Health Dear Administrator: In March 2000, the Department of Health issued a Dear Administrator Letter (DAL 00-04) describing the responsibilities of nursing homes in reporting abuse, mistreatment and neglect. In December...»

«Functional characterization of LINC complex protein assemblies and their role in laminopathies INAUGURAL-DISSERTATION zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultät der Universität zu Köln vorgelegt von Liu Yang aus Runan, Henan, P. R. China Köln, 2013 Referees/Berichterstatter: Prof. Dr. Angelika A. Noegel Prof. Dr. Arnd Baumann Prüfungsvorsitzender: Prof. Dr. Siegfried Roth Date of oral examination: 25.06.2013 Tag der mündlichen Prüfung The present...»

«Columbia Population Research Center Advancing Research in Population, Health, and Society CPRC CPRC Working Paper No. 10-03 Race and Selective Enforcement in Public Housing Jeffrey Fagan Columbia Law School Garth Davies School of Criminology Simon Fraser University Adam Carlis Columbia Law School April, 2010 Unpublished manuscript. Do not copy or cite without author permission. 1255 Amsterdam Avenue ▪ New York, New York ▪ 10027 cupop.columbia.edu...»

«SURROGACY AND A PREGNANT WOMAN’S CONSTITUTIONAL RIGHT TO MEDICAL AND PROCREATIVE CHOICE – A BRIEF SURVEY Deborah H. Wald, Esq. & Katherine Black, J.D. candidate © October 2011 In analyzing the constitutional rights of surrogates, it seems prudent to assume that a surrogate – whether a traditional surrogate or a gestational carrier1 – retains all the constitutional rights of any other pregnant woman up until the moment of birth. Whether this assumption is, in fact, true, may depend on a...»

«2014 San Antonio Breastfeeding Coalition Conference F e b r u a r y 7 8, 2 014 Managing Breastfeeding with Oral Challenges in the Infant Featuring: Texas Breastfeeding Initiatives February 7th 7:00-10:00 PM SABC “Deep in the Heart of Texas” Gala La Quinta Inn & Suites Conference Center 4431 Horizon Hill Blvd, San Antonio, Texas Join us in San Antonio for the 2014 Texas Breastfeeding Summit and experience a diverse culture of authentic foods, music and art represented by Old Mexico, the...»

«Available online at www.sciencedirect.com Procedia Engineering Procedia Engineering 20 (2011) 135 – 146 Procedia Social and Behavioral Sciences 00 (2011) 000–000 www.elsevier.com/locate/procedia The 2nd International Building Control Conference 2011 “Usability Evaluation”: Criteria for Quality Architecture InUse S.N.Haruna*, M.Y.Hamida, A.Talibb, Z.A.Rahimc a Faculty Achitecture, Panning & Survey,Universiti Teknologi MARA Perak, 32610, Seri Iskandar, Perak, MALAYSIA b Faculty...»





 
<<  HOME   |    CONTACTS
2016 www.dissertation.xlibx.info - Dissertations, online materials

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.